Regeneron is just starting a clinical trial of PFS vs AI and pharmacokinetics with an estimated completion date of February 2018. https://clinicaltrials.gov/ct2/show/NCT03050151?term=dupilumab&rank=11
Diversification and low trading fees: Is this the ‘secret sauce’ to saving your investment portfolio?